As FKN had a positive effect over anti-tumor activities in colorectal cancer, Siddiqui et al. modified human T cells to express the FKN receptor, which favored trafficking to FKN-expressing tumors with a resulting decrease in tumor growth through CTL activities in adoptive transfer experiments in mice [74]. This evidence concerns the gene CX3CL1 and colorectal cancer.